|Institutional Source||Beutler Lab|
|Gene Name||nitric oxide synthase 2, inducible|
|Synonyms||iNOS, Nos-2, Nos2a, NOS-II|
|Is this an essential gene?||Non essential (E-score: 0.000)|
|Stock #||R6706 (G1)|
|Chromosomal Location||78920787-78960254 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to G at 78944723 bp|
|Amino Acid Change||Asparagine to Aspartic acid at position 443 (N443D)|
|Ref Sequence||ENSEMBL: ENSMUSP00000018610 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000018610] [ENSMUST00000214397]|
|Predicted Effect||possibly damaging
AA Change: N443D
PolyPhen 2 Score 0.597 (Sensitivity: 0.87; Specificity: 0.91)
AA Change: N443D
|Predicted Effect||probably benign
AA Change: N330D
PolyPhen 2 Score 0.281 (Sensitivity: 0.91; Specificity: 0.88)
|Meta Mutation Damage Score||0.04|
|Coding Region Coverage||
|Validation Efficiency||97% (36/37)|
FUNCTION: Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase that is inducible by a combination of lipopolysaccharide and certain cytokines. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
PHENOTYPE: Homozygous deletion of this gene alters susceptibility to infection, response to injury, sepsis and sensory stimuli, cardiac function, osteoclast, platelet and mammary gland physiology, tumor growth, testis and uterus morphology, diet-induced atherosclerosis, and blood, urine and glucose metabolism. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Nos2||
(F):5'- TGTTTCTGCAGCAGTCAGTG -3'
(R):5'- AGTCTCCACAGCTGAGCTATAAG -3'
(F):5'- TTTCTGCAGCAGTCAGTGAGAAC -3'
(R):5'- CTCCACAGCTGAGCTATAAGATGGG -3'